Expression, purification and preliminary biochemical and structural characterization of the leucine rich repeat namesake domain of leucine rich repeat kinase 2

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1824, Issue 3, 2012, Pages 450-460

  Vancraenenbroeck, Renée ^a   Lobbestael, Evy ^a   Weeks, Stephen D ^b   Strelkov, Sergei V ^b   Baekelandt, Veerle ^a   Taymans, Jean Marc ^a   De Maeyer, Marc ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b DEPARTMENT OF PHARMACEUTICAL AND PHARMACOLOGICAL SCIENCES   (Belgium)

Author keywords

Homology modeling; Leucine rich repeat; Parkinson's disease: leucine rich repeat kinase 2; Protein purification

Indexed keywords

GUANOSINE TRIPHOSPHATASE; LEUCINE RICH REPEAT KINASE 2;

ARTICLE; CIRCULAR DICHROISM; CROSS LINKING; GEL PERMEATION CHROMATOGRAPHY; MOLECULAR INTERACTION; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION;

AMINO ACID SEQUENCE; CHROMATOGRAPHY, GEL; CIRCULAR DICHROISM; ESCHERICHIA COLI; HEK293 CELLS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LIGHT; MOLECULAR SEQUENCE DATA; MUTATION; ORGANIC CHEMICALS; PARKINSON DISEASE; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES; RECOMBINANT PROTEINS; SCATTERING, RADIATION; SEQUENCE ALIGNMENT;

ESCHERICHIA COLI;

EID: 84856086632     PISSN: 15709639     EISSN: 18781454     Source Type: Journal    
DOI: 10.1016/j.bbapap.2011.12.009     Document Type: Article

References (76)

1. O. Corti, S. Lesage, and A. Brice What genetics tells us about the causes and mechanisms of Parkinson's disease Physiol. Rev. 91 2011 1161 1218
2. U. Kumari, and E.K. Tan LRRK2 in Parkinson's disease: genetic and clinical studies from patients FEBS J. 276 2009 6455 6463
3. J. Simon-Sanchez, C. Schulte, J.M. Bras, M. Sharma, J.R. Gibbs, D. Berg, C. Paisan-Ruiz, P. Lichtner, S.W. Scholz, D.G. Hernandez, R. Kruger, M. Federoff, C. Klein, A. Goate, J. Perlmutter, M. Bonin, M.A. Nalls, T. Illig, C. Gieger, H. Houlden, M. Steffens, M.S. Okun, B.A. Racette, M.R. Cookson, K.D. Foote, H.H. Fernandez, B.J. Traynor, S. Schreiber, S. Arepalli, R. Zonozi, K. Gwinn, M. van der Brug, G. Lopez, S.J. Chanock, A. Schatzkin, Y. Park, A. Hollenbeck, J. Gao, X. Huang, N.W. Wood, D. Lorenz, G. Deuschl, H. Chen, O. Riess, J.A. Hardy, A.B. Singleton, and T. Gasser Genome-wide association study reveals genetic risk underlying Parkinson's disease Nat. Genet. 41 2009 1308 1312
4. W. Satake, Y. Nakabayashi, I. Mizuta, Y. Hirota, C. Ito, M. Kubo, T. Kawaguchi, T. Tsunoda, M. Watanabe, A. Takeda, H. Tomiyama, K. Nakashima, K. Hasegawa, F. Obata, T. Yoshikawa, H. Kawakami, S. Sakoda, M. Yamamoto, N. Hattori, M. Murata, Y. Nakamura, and T. Toda Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease Nat. Genet. 41 2009 1303 1307
5. J.M. Taymans, and M.R. Cookson Mechanisms in dominant parkinsonism: the toxic triangle of LRRK2, alpha-synuclein, and tau Bioessays 32 2010 227 235
6. I.F. Mata, W.J. Wedemeyer, M.J. Farrer, J.P. Taylor, and K.A. Gallo LRRK2 in Parkinson's disease: protein domains and functional insights Trends Neurosci. 29 2006 286 293
7. L. Bosgraaf, and P.J. Van Haastert Roc, a Ras/GTPase domain in complex proteins Biochim. Biophys. Acta 1643 2003 5 10 (Pubitemid 37494887)
8. K. Nuytemans, J. Theuns, M. Cruts, and C. Van Broeckhoven Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update Hum. Mutat. 31 2010 763 780
9. D. Berg, K.J. Schweitzer, P. Leitner, A. Zimprich, P. Lichtner, P. Belcredi, T. Brussel, C. Schulte, S. Maass, T. Nagele, Z.K. Wszolek, and T. Gasser Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease* Brain 128 2005 3000 3011
10. A.S. Chen-Plotkin, W. Yuan, C. Anderson, E. McCarty Wood, H.I. Hurtig, C.M. Clark, B.L. Miller, V.M. Lee, J.Q. Trojanowski, M. Grossman, and V.M. Van Deerlin Corticobasal syndrome and primary progressive aphasia as manifestations of LRRK2 gene mutations Neurology 70 2008 521 527 (Pubitemid 351653376)
11. J.P. Covy, W. Yuan, E.A. Waxman, H.I. Hurtig, V.M. Van Deerlin, and B.I. Giasson Clinical and pathological characteristics of patients with leucine-rich repeat kinase-2 mutations Mov. Disord. 24 2009 32 39
12. I.F. Mata, J.M. Kachergus, J.P. Taylor, S. Lincoln, J. Aasly, T. Lynch, M.M. Hulihan, S.A. Cobb, R.M. Wu, C.S. Lu, C. Lahoz, Z.K. Wszolek, and M.J. Farrer Lrrk2 pathogenic substitutions in Parkinson's disease Neurogenetics 6 2005 171 177 (Pubitemid 41720888)
13. W.C. Nichols, V.E. Elsaesser, N. Pankratz, M.W. Pauciulo, D.K. Marek, C.A. Halter, A. Rudolph, C.W. Shults, and T. Foroud LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8 Neurology 69 2007 1737 1744 (Pubitemid 350059302)
14. K. Nuytemans, B. Meeus, D. Crosiers, N. Brouwers, D. Goossens, S. Engelborghs, P. Pals, B. Pickut, M. Van den Broeck, E. Corsmit, P. Cras, P.P. De Deyn, J. Del-Favero, C. Van Broeckhoven, and J. Theuns Relative contribution of simple mutations vs. copy number variations in five Parkinson disease genes in the Belgian population Hum. Mutat. 30 2009 1054 1061
15. L. Skipper, Y. Li, C. Bonnard, R. Pavanni, Y. Yih, E. Chua, W.K. Sung, L. Tan, M.C. Wong, E.K. Tan, and J. Liu Comprehensive evaluation of common genetic variation within LRRK2 reveals evidence for association with sporadic Parkinson's disease Hum. Mol. Genet. 14 2005 3549 3556 (Pubitemid 41754656)
16. C.P. Zabetian, M. Yamamoto, A.N. Lopez, H. Ujike, I.F. Mata, Y. Izumi, R. Kaji, H. Maruyama, H. Morino, M. Oda, C.M. Hutter, K.L. Edwards, G.D. Schellenberg, D.W. Tsuang, D. Yearout, E.B. Larson, and H. Kawakami LRRK2 mutations and risk variants in Japanese patients with Parkinson's disease Mov. Disord. 24 2009 1034 1041
17. A. Zimprich, S. Biskup, P. Leitner, P. Lichtner, M. Farrer, S. Lincoln, J. Kachergus, M. Hulihan, R.J. Uitti, D.B. Calne, A.J. Stoessl, R.F. Pfeiffer, N. Patenge, I.C. Carbajal, P. Vieregge, F. Asmus, B. Muller-Myhsok, D.W. Dickson, T. Meitinger, T.M. Strom, Z.K. Wszolek, and T. Gasser Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology Neuron 44 2004 601 607 (Pubitemid 39531225)
18. B. Kobe, and J. Deisenhofer Proteins with leucine-rich repeats Curr. Opin. Struct. Biol. 5 1995 409 416
19. S.G. Buchanan, and N.J. Gay Structural and functional diversity in the leucine-rich repeat family of proteins Prog. Biophys. Mol. Biol. 65 1996 1 44 (Pubitemid 27161007)
20. B. Kobe, and J. Deisenhofer Crystal structure of porcine ribonuclease inhibitor, a protein with leucine-rich repeats Nature 366 1993 751 756 (Pubitemid 24038517)
21. A.V. Kajava Structural diversity of leucine-rich repeat proteins J. Mol. Biol. 277 1998 519 527 (Pubitemid 28190855)
22. B. Kobe, and A.V. Kajava The leucine-rich repeat as a protein recognition motif Curr. Opin. Struct. Biol. 11 2001 725 732 (Pubitemid 34076634)
23. A.C. Ng, J.M. Eisenberg, R.J. Heath, A. Huett, C.M. Robinson, G.J. Nau, and R.J. Xavier Human leucine-rich repeat proteins: a genome-wide bioinformatic categorization and functional analysis in innate immunity Proc Natl Acad Sci U S A 107 Suppl 1 2010 4631 4638
24. B. Petersen, T.N. Petersen, P. Andersen, M. Nielsen, and C. Lundegaard A generic method for assignment of reliability scores applied to solvent accessibility predictions BMC Struct. Biol. 9 2009 51
25. A.V. Kajava, G. Vassart, and S.J. Wodak Modeling of the three-dimensional structure of proteins with the typical leucine-rich repeats Structure 3 1995 867 877
26. T. Wei, J. Gong, F. Jamitzky, W.M. Heckl, R.W. Stark, and S.C. Rossle LRRML: a conformational database and an XML description of leucine-rich repeats (LRRs) BMC Struct. Biol. 8 2008 47
27. L. Mosyak, A. Wood, B. Dwyer, M. Buddha, M. Johnson, A. Aulabaugh, X. Zhong, E. Presman, S. Benard, K. Kelleher, J. Wilhelm, M.L. Stahl, R. Kriz, Y. Gao, Z. Cao, H.P. Ling, M.N. Pangalos, F.S. Walsh, and W.S. Somers The structure of the Lingo-1 ectodomain, a module implicated in central nervous system repair inhibition J. Biol. Chem. 281 2006 36378 36390 (Pubitemid 46041372)
28. M. Pawlowski, M.J. Gajda, R. Matlak, and J.M. Bujnicki MetaMQAP: a meta-server for the quality assessment of protein models BMC Bioinformatics 9 2008 403
29. G. Ito, T. Okai, G. Fujino, K. Takeda, H. Ichijo, T. Katada, and T. Iwatsubo GTP binding is essential to the protein kinase activity of LRRK2, a causative gene product for familial Parkinson's disease Biochemistry 46 2007 1380 1388 (Pubitemid 46208485)
30. G. Bohm, R. Muhr, and R. Jaenicke Quantitative analysis of protein far UV circular dichroism spectra by neural networks Protein Eng. 5 1992 191 195
31. J. Bella, K.L. Hindle, P.A. McEwan, and S.C. Lovell The leucine-rich repeat structure Cell. Mol. Life Sci. 65 2008 2307 2333
32. E. Greggio, J.M. Taymans, E.Y. Zhen, J. Ryder, R. Vancraenenbroeck, A. Beilina, P. Sun, J. Deng, H. Jaffe, V. Baekelandt, K. Merchant, and M.R. Cookson The Parkinson's disease kinase LRRK2 autophosphorylates its GTPase domain at multiple sites Biochem. Biophys. Res. Commun. 389 2009 449 454
33. C.J. Gloeckner, K. Boldt, F. von Zweydorf, S. Helm, L. Wiesent, H. Sarioglu, and M. Ueffing Phosphopeptide analysis reveals two discrete clusters of phosphorylation in the N-terminus and the Roc domain of the Parkinson-disease associated protein kinase LRRK2 J. Proteome Res. 9 2010 1738 1745
34. P.P. Pungaliya, Y. Bai, K. Lipinski, V.S. Anand, S. Sen, E.L. Brown, B. Bates, P.H. Reinhart, A.B. West, W.D. Hirst, and S.P. Braithwaite Identification and characterization of a leucine-rich repeat kinase 2 (LRRK2) consensus phosphorylation motif PLoS One 5 2010 e13672
35. S. Sahdev, S.K. Khattar, and K.S. Saini Production of active eukaryotic proteins through bacterial expression systems: a review of the existing biotechnology strategies Mol. Cell. Biochem. 307 2008 249 264 (Pubitemid 50006245)
36. T. Kiefhaber, R. Rudolph, H.H. Kohler, and J. Buchner Protein aggregation in vitro and in vivo: a quantitative model of the kinetic competition between folding and aggregation Biotechnology (N. Y) 9 1991 825 829
37. V. Daniels, R. Vancraenenbroeck, B.M. Law, E. Greggio, E. Lobbestael, F. Gao, M. De Maeyer, M.R. Cookson, K. Harvey, V. Baekelandt, and J.M. Taymans Insight into the mode of action of the LRRK2 Y1699C pathogenic mutant J. Neurochem. 116 2011 304 315
38. C. Li, and M.F. Beal Leucine-rich repeat kinase 2: a new player with a familiar theme for Parkinson's disease pathogenesis Proc. Natl. Acad. Sci. U.S.A. 102 2005 16535 16536 (Pubitemid 41688810)
39. N. Matsushima, N. Tachi, Y. Kuroki, P. Enkhbayar, M. Osaki, M. Kamiya, and R.H. Kretsinger Structural analysis of leucine-rich-repeat variants in proteins associated with human diseases Cell. Mol. Life Sci. 62 2005 2771 2791 (Pubitemid 41779946)
40. L. Guo, P.N. Gandhi, W. Wang, R.B. Petersen, A.L. Wilson-Delfosse, and S.G. Chen The Parkinson's disease-associated protein, leucine-rich repeat kinase 2 (LRRK2), is an authentic GTPase that stimulates kinase activity Exp. Cell Res. 313 2007 3658 3670 (Pubitemid 47404550)
41. J. Field, A. Vojtek, R. Ballester, G. Bolger, J. Colicelli, K. Ferguson, J. Gerst, T. Kataoka, T. Michaeli, S. Powers, M. Riggs, L. Rodgers, I. Wieland, B. Wheland, and M. Wigler Cloning and characterization of CAP, the S. cerevisiae gene encoding the 70 kd adenylyl cyclase-associated protein Cell 61 1990 319 327
42. Y.T. Liu, and H.L. Yin Identification of the binding partners for flightless I, a novel protein bridging the leucine-rich repeat and the gelsolin superfamilies J. Biol. Chem. 273 1998 7920 7927 (Pubitemid 28168839)
43. J.C. Abysalh, L.L. Kuchnicki, and D.A. Larochelle The identification of pats1, a novel gene locus required for cytokinesis in Dictyostelium discoideum Mol. Biol. Cell 14 2003 14 25 (Pubitemid 36106016)
44. N.R. Forsthoefel, K. Cutler, M.D. Port, T. Yamamoto, and D.M. Vernon PIRLs: a novel class of plant intracellular leucine-rich repeat proteins Plant Cell Physiol. 46 2005 913 922 (Pubitemid 41435478)
45. F.R. Bischoff, C. Klebe, J. Kretschmer, A. Wittinghofer, and H. Ponstingl RanGAP1 induces GTPase activity of nuclear Ras-related Ran Proc. Natl. Acad. Sci. U.S.A. 91 1994 2587 2591 (Pubitemid 24139392)
46. M.L. Cutler, R.H. Bassin, L. Zanoni, and N. Talbot Isolation of rsp-1, a novel cDNA capable of suppressing v-Ras transformation Mol. Cell. Biol. 12 1992 3750 3756
47. D.S. Sieburth, Q. Sun, and M. Han SUR-8, a conserved Ras-binding protein with leucine-rich repeats, positively regulates Ras-mediated signaling in C. elegans Cell 94 1998 119 130 (Pubitemid 28347475)
48. D.C. Berwick, and K. Harvey LRRK2 signaling pathways: the key to unlocking neurodegeneration? Trends Cell Biol. 21 2011 257 265
49. V. Daniels, V. Baekelandt, and J.M. Taymans On the road to leucine-rich repeat kinase 2 signalling: evidence from cellular and in vivo studies Neurosignals 19 2011 1 15
50. N. Shin, H. Jeong, J. Kwon, H.Y. Heo, J.J. Kwon, H.J. Yun, C.H. Kim, B.S. Han, Y. Tong, J. Shen, T. Hatano, N. Hattori, K.S. Kim, S. Chang, and W. Seol LRRK2 regulates synaptic vesicle endocytosis Exp. Cell Res. 314 2008 2055 2065
51. M.J. Seewald, C. Korner, A. Wittinghofer, and I.R. Vetter RanGAP mediates GTP hydrolysis without an arginine finger Nature 415 2002 662 666 (Pubitemid 34136396)
52. J.B. Janosi, P.A. Ramsland, M.R. Mott, S.M. Firth, R.C. Baxter, and P.J. Delhanty The acid-labile subunit of the serum insulin-like growth factor-binding protein complexes. Structural determination by molecular modeling and electron microscopy J. Biol. Chem. 274 1999 23328 23332
53. J. Montgomery, T. Ilg, J.K. Thompson, B. Kobe, and E. Handman Identification and predicted structure of a leucine-rich repeat motif shared by Leishmania major proteophosphoglycan and Parasite Surface Antigen 2 Mol. Biochem. Parasitol. 107 2000 289 295 (Pubitemid 30211643)
54. J. Hines, E. Skrzypek, A.V. Kajava, and S.C. Straley Structure-function analysis of Yersinia pestis YopM's interaction with alpha-thrombin to rule on its significance in systemic plague and to model YopM's mechanism of binding host proteins Microb. Pathog. 30 2001 193 209 (Pubitemid 32565138)
55. T. Wei, J. Gong, S.C. Rossle, F. Jamitzky, W.M. Heckl, and R.W. Stark A leucine-rich repeat assembly approach for homology modeling of the human TLR5-10 and mouse TLR11-13 ectodomains J. Mol. Model. 17 2011 27 36
56. K.L. Hindle, J. Bella, and S.C. Lovell Quantitative analysis and prediction of curvature in leucine-rich repeat proteins Proteins 77 2009 342 358
57. S. Frankel, R. Sohn, and L. Leinwand The use of sarkosyl in generating soluble protein after bacterial expression Proc. Natl. Acad. Sci. U.S.A. 88 1991 1192 1196 (Pubitemid 21916191)
58. B. Kobe, and J. Deisenhofer The leucine-rich repeat: a versatile binding motif Trends Biochem. Sci. 19 1994 415 421 (Pubitemid 24320131)
59. T.M. Hering, J. Kollar, T.D. Huynh, and J.B. Varelas Purification and characterization of decorin core protein expressed in Escherichia coli as a maltose-binding protein fusion Anal. Biochem. 240 1996 98 108 (Pubitemid 26292927)
60. J. Haberland, J. Becker, and V. Gerke The acidic C-terminal domain of rna1p is required for the binding of Ran.GTP and for RanGAP activity J. Biol. Chem. 272 1997 24717 24726 (Pubitemid 27418692)
61. A. Majerle, J. Kidric, and R. Jerala Bacterial expression and refolding of different fragments of human CD14 Pflugers Arch. 439 2000 R109 R110
62. O.O. Kolade, V.A. Bamford, G. Ancillo Anton, J.D. Jones, P. Vera, and A.M. Hemmings In vitro characterization of the cysteine-rich capping domains in a plant leucine rich repeat protein Biochim. Biophys. Acta 1764 2006 1043 1053
63. A.J. Afzal, and D.A. Lightfoot Soybean disease resistance protein RHG1-LRR domain expressed, purified and refolded from Escherichia coli inclusion bodies: preparation for a functional analysis Protein Expr. Purif. 53 2007 346 355 (Pubitemid 46464022)
64. R. Rudolph, and H. Lilie In vitro folding of inclusion body proteins FASEB J. 10 1996 49 56 (Pubitemid 26035506)
65. T. Zhang, X. Xu, L. Shen, Y. Feng, Z. Yang, Y. Shen, J. Wang, W. Jin, and X. Wang Modeling of protein refolding from inclusion bodies Acta. Biochim. Biophys. Sin. (Shanghai) 41 2009 1044 1052
66. J.A. Thorson, L.W. Yu, A.L. Hsu, N.Y. Shih, P.R. Graves, J.W. Tanner, P.M. Allen, H. Piwnica-Worms, and A.S. Shaw 14-3-3 proteins are required for maintenance of Raf-1 phosphorylation and kinase activity Mol. Cell. Biol. 18 1998 5229 5238 (Pubitemid 28388106)
67. T. Takagi, and K. Kubo Sodium dodecyl sulfate-protein polypeptide complexes in 8 M urea with special reference to sodium dodecyl sulfate-polyacrylamide gel electrophoresis Biochim. Biophys. Acta 578 1979 68 75
68. M.T. Stumpp, P. Forrer, H.K. Binz, and A. Pluckthun Designing repeat proteins: modular leucine-rich repeat protein libraries based on the mammalian ribonuclease inhibitor family J. Mol. Biol. 332 2003 471 487 (Pubitemid 37020958)
69. Z.E. Newby, J.D. O'Connell III, F. Gruswitz, F.A. Hays, W.E. Harries, I.M. Harwood, J.D. Ho, J.K. Lee, D.F. Savage, L.J. Miercke, and R.M. Stroud A general protocol for the crystallization of membrane proteins for X-ray structural investigation Nat. Protoc. 4 2009 619 637
70. C.J. Gloeckner, N. Kinkl, A. Schumacher, R.J. Braun, E. O'Neill, T. Meitinger, W. Kolch, H. Prokisch, and M. Ueffing The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity Hum. Mol. Genet. 15 2006 223 232 (Pubitemid 43125977)
71. J. Deng, P.A. Lewis, E. Greggio, E. Sluch, A. Beilina, and M.R. Cookson Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase Proc. Natl. Acad. Sci. U.S.A. 105 2008 1499 1504 (Pubitemid 351346543)
72. K. Gotthardt, M. Weyand, A. Kortholt, P.J. Van Haastert, and A. Wittinghofer Structure of the Roc-COR domain tandem of C. tepidum, a prokaryotic homologue of the human LRRK2 Parkinson kinase EMBO J. 27 2008 2352
73. E. Greggio, I. Zambrano, A. Kaganovich, A. Beilina, J.M. Taymans, V. Daniels, P. Lewis, S. Jain, J. Ding, A. Syed, K.J. Thomas, V. Baekelandt, and M.R. Cookson The Parkinson disease-associated leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylation J. Biol. Chem. 283 2008 16906 16914
74. C.L. Klein, G. Rovelli, W. Springer, C. Schall, T. Gasser, and P.J. Kahle Homo- and heterodimerization of ROCO kinases: LRRK2 kinase inhibition by the LRRK2 ROCO fragment J. Neurochem. 111 2009 703 715
75. Y. Li, L. Dunn, E. Greggio, B. Krumm, G.S. Jackson, M.R. Cookson, P.A. Lewis, and J. Deng The R1441C mutation alters the folding properties of the ROC domain of LRRK2 Biochim. Biophys. Acta 1792 2009 1194 1197
76. S. Sen, P.J. Webber, and A.B. West Dependence of leucine-rich repeat kinase 2 (LRRK2) kinase activity on dimerization J. Biol. Chem. 284 2009 36346 36356